Building an ecosystem to advance BNCT as an effective and convenient treatment modality
Founded by Deerfield Management
Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy. The Firm works across the healthcare ecosystem to connect people, capital, ideas and technology in bold, collaborative and inclusive ways.
Supported by Deerfield Discovery and Development (“3DC”) and Deerfield External Operations
Aviko is supported by a team of drug development and operations professionals from Deerfield Management. The Deerfield 3DC team provides integrated drug development capabilities from early-stage drug discovery through pre-clinical testing and into human clinical trials. The Deerfield external operations team provides a range of financial and business development support to Aviko.
Our team is comprised of leaders in drug development, operations and business development who are committed to advancing boron neutron capture therapy and expanding access to this promising modality to patients in the U.S. We are based at Cure., a healthcare innovation campus in New York City.
Sam Bakri, M.D., MBA
Mike Fiore, MBA
If you would like to learn more about partnering to expand access to BNCT, please get in touch.
We partner with chemists, biologists and other biopharma companies to develop next generation BNCT medicines.
We are building partnerships with leading medical centers to provide BNCT care to patients.